DE SB138

Permits rigorous scientific research on medical marijuana safety and efficacy in Delaware facilities that meet FDA-accepted security and operational standards.

Establishes that research facilities conducting marijuana studies under this chapter are protected from prosecution, seizure, search (except by the Department), civil penalties, or disciplinary action by licensing boards.

Requires research to use practices ensuring uniformity, consistency, reliability, reproducibility, quality, and integrity of data, including good laboratory standards (GLP) when required.

Mandates that research must be conducted using plants grown from well-characterized and well-defined seed stock.

Aligns Delaware research procedures with National Institutes of Health guidelines and federal oversight by the National Institute of Drug Abuse.